No Data
IceCure Medical Announces That A Large Number Of Public Comments Have Been Posted From Key Stakeholders Ahead Of The U.S. FDA Medical Device Advisory Committee Panel For Marketing Authorization Of ProSense Cryoablation In Early-Stage Low Risk Breast...
IceCure Medical Expands Patent Portfolio With New US Approval
Express News | Icecure Receives Notice of Allowance From U.S. Patent and Trademark Office for Its Next-Generation Cryoablation System
IceCure Medical Offering Shares and Warrants
Icecure Medical: A Strong Buy on Clinical Success and Upcoming Regulatory Catalysts
IceCure's ProSense Cryoablation Featured In Six Global Studies At 2024 EUSOBI Conference
No Data
No Data